Cargando…
Enhanced Antitumor Immunity in Mice Deficient in CD69
We investigated the in vivo role of CD69 by analyzing the susceptibility of CD69−/− mice to tumors. CD69−/− mice challenged with MHC class I(−) tumors (RMA-S and RM-1) showed greatly reduced tumor growth and prolonged survival compared with wild-type (WT) mice. The enhanced anti–tumor response was N...
Autores principales: | Esplugues, Enric, Sancho, David, Vega-Ramos, Javier, Martínez-A, Carlos, Syrbe, Uta, Hamann, Alf, Engel, Pablo, Sánchez-Madrid, Francisco, Lauzurica, Pilar |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2193974/ https://www.ncbi.nlm.nih.gov/pubmed/12732655 http://dx.doi.org/10.1084/jem.20021337 |
Ejemplares similares
-
CD69 Does Not Affect the Extent of T Cell Priming
por: Alari-Pahissa, Elisenda, et al.
Publicado: (2012) -
Functional Characterization of a Dual Enhancer/Promoter Regulatory Element Leading Human CD69 Expression
por: Redondo-Antón, Jennifer, et al.
Publicado: (2020) -
Unraveling CD69 signaling pathways, ligands and laterally associated molecules
por: Jiménez-Fernández, María, et al.
Publicado: (2023) -
The Conserved Non-Coding Sequence 2 (CNS2) Enhances CD69 Transcription through Cooperation between the Transcription Factors Oct1 and RUNX1
por: Fontela, Miguel G., et al.
Publicado: (2019) -
Regulation and Migratory Role of P-Selectin Ligands during Intestinal Inflammation
por: Hoffmann, Ute, et al.
Publicado: (2013)